We further combined cognitive and pathological diagnoses and found that cortical GFAP transcript and protein levels are upregulated in participants with pathologically confirmed AD compared to cognitively unimpaired, pathology-negative individuals (Supplementary Fig. 1). Here, GFAP is linked to Alzheimer disease.